May 28, 2024 | 19:00 PM CEST | seqera

Seqera Sessions, Barcelona

Join us for an unforgettable evening of insights, networking, and fun at Seqera Sessions Barcelona on May 28, from 7:00 PM onward!

Seqera Sessions, Barcelona

About

What to expect:

  • The founders of Nextflow and Seqera will kick off the evening with a warm welcome followed by a panel featuring bioinformatics thought leaders in biopharma and biotech industry.
  • Networking with the scientific community, connecting with peers, experts, and innovators.
  • Delicious food and drinks from a local Michelin-starred restaurant, set against the backdrop of the waterfront, the perfect combination to mingle!
  • Immersive VR Sailing Experience aboard an Alinghi Boat at the Alinghi Base

This event is open to: bioinformaticians, data scientists, computational biologists and those attending SLAS Europe. A shuttle will be provided from SLAS.

Don’t miss this opportunity to engage, learn, and connect with industry leaders and fellow enthusiasts!

This event has limited space, so register soon to secure your spot.

ARBR Base, Barcelona

Agenda

6:45 PM

Shuttle departure from SLAS Europe Conference

7:00 PM

Shuttle Arrival - Registration open

7:20 PM

Welcome by Evan Floden, Seqera CEO and Co-founder

7:30 PM

The Earth BioGenome Project: A Foundation for the New Bioeconomy by Harris A. Lewin

7:45 PM

Industry Panel with AstraZeneca, CRG, Josep Carreras Leukemia Research Institute and Seqera

8:10 PM

Food & Drinks

10 PM

End

Speakers

Evan Floden

Evan Floden

CEO & Co-founder at Seqera, a company empowering scientists to solve today's most complex and essential challenges; from pioneering innovative therapeutics to unveiling the secrets of our universe.

Paolo Di Tommaso

Paolo Di Tommaso

CTO & Co-founder at Seqera

Melinda Pautsch

Melinda Pautsch

Chief Revenue Officer at Seqera

Robert Lalonde

Robert Lalonde

Chief of Commercial Partnerships at Seqera

Stacy Gorelik

Stacy Gorelik

VP Engineering at Seqera

Noel Ortiz

Noel Ortiz

VP of Marketing & Growth at Seqera